Sat, Mar 17, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

GPP expands in Europe

Tuesday, September 10, 2013
Opalesque Industry Update, for New Managers - Global Prime Partners ("GPP"), the global prime brokerage boutique which specialises in supporting emerging managers, has further built out its sales team in Europe just weeks after announcing the expansion of its client service capabilities into the Asian markets.

GPP announced the hire of Colin Bridges who joined the firm on 01 September from BNP Paribas in London. Colin will work closely with Kevin LoPrimo, Head of Hedge Fund Services at GPP, to develop and to support the firm's rapidly growing list of prime brokerage clients across Europe. Colin will be focused on selling the GPP product to hedge funds, family offices, and proprietary traders across Europe and brings to GPP a wealth of experience gained in the Prime Brokerage arena.

Colin previously spent five years at BNP Paribas working on the Equity Financing desk based in London. Here he covered European hedge fund clients and was instrumental in stream-lining the on boarding process for the bank's cash and synthetic prime brokerage business. He is a graduate of the University of Bath with a degree in [BSc (Hons)] Business Administration.

In announcing the appointment, Julian Parker, CEO of GPP, commented: "Colin brings much needed sales support to GPP at a time of above average growth in the smaller hedge fund space. His experience and background are very relevant to the emerging managers arena and we are extremely pleased to be able to welcome him to Global Prime Partners. "

Colin Bridges noted: "GPP's dynamic management has delivered outstanding growth in the past few years. I am excited to be joining a firm that is so clearly and strongly establishing its footprint in the European prime brokerage market."

Press Release


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t